Could the presence of adrenal incidentaloma negatively affect COVID 19 outcomes?

Metin GüçlüBilal Burcak AslanTirdad SetayeshiSinem Kiyici

Published in: Endocrine (2023)

The presence of AI may increase the morbidity and mortality rates associated with COVID-19, regardless of their functional status. Therefore, patients subjected to CCT imaging for COVID-19-related lung diseases should also be evaluated for AI. Careful follow-up of patients with COVID-19 and AI is necessary to monitor the progression of COVID-19.

Keyphrases

coronavirus disease
sars cov
artificial intelligence
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
type diabetes
machine learning
adipose tissue
patient reported outcomes
skeletal muscle